ACELRX PHARMACEUTICALS WKN: A1H64B ISIN: US00444T1007 Kürzel: R5X Forum: Aktien Thema: Hauptdiskussion

Dir würde ich ja mal gönnen das der Puff explodiert so lange wir du schon dabei bist. 2018 oder 2019? ✌

Immerhin nettes Volumen innerhalb der letzten Stunde.

Minus in Serie...

AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update https://www.acelrx.com/news-releases/news-release-details/acelrx-pharmaceuticals-reports-second-quarter-2022-financial Advanced Niyad™ supply chain development with a focus on obtaining an Emergency Use Authorization in 2023 $0.6 million net revenue in Q2 2022; fifth consecutive quarter of commercial (ex-DoD) sales volume growth for DSUVIA, with a 133% increase compared to Q2 2021; on track for EU launch of DZUVEO in the third quarter Projected annual savings of $9 million beginning in June 2022 from realigned cost structure $27.9 million in cash and short-term investments as of June 30, 2022 $84.1 million gain on extinguishment of debt due to termination of royalty monetization ...

Schade sah erst gut aus

Dort x10

Ich würde sagen 500%

💪💪

200% heute

Wird wahrscheinlich bis 200% gehen👍

👀

OHAAA O NE LAN 👀

🍀🤩

👀

oh my gosh

=00=